ID

18979

Beschreibung

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00126230

Link

https://clinicaltrials.gov/show/NCT00126230

Stichworte

  1. 28.11.16 28.11.16 -
Hochgeladen am

28. November 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00126230

Eligibility Prostate Cancer NCT00126230

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients older than 18 years and less than 80 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
histologically-proven adenocarcinoma of the prostate
Beschreibung

Adenocarcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0007112
evidence of bone metastases and progressive, hormone-refractory, disease
Beschreibung

Secondary malignant neoplasm of bone Evidence | Progressive Disease Hormones refractory

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0153690
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C1335499
UMLS CUI [2,2]
C0019932
UMLS CUI [2,3]
C0205269
no previous chemotherapy
Beschreibung

Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
no previous radiotherapy, except radiotherapy directed to the prostate and/or to a single bony lesion
Beschreibung

Therapeutic radiology procedure | Radiotherapy to prostate | Therapeutic radiology procedure Bone lesion Single

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0948317
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0238792
UMLS CUI [3,3]
C0205171
no previous carcinoma, except basal-cell carcinoma of the skin
Beschreibung

Carcinoma | Basal cell carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0007097
UMLS CUI [2]
C0007117
adequate renal function: measured or calculated creatinine clearance > 60 ml/min
Beschreibung

Renal function | Creatinine clearance measurement | Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0373595
UMLS CUI [3]
C2711451
absolute granulocyte count ≥ 1,500/mm3, platelets ≥ 100,000 mm3, bilirubin ≤ 1.5 fold the upper normal value
Beschreibung

Absolute neutrophil count | Platelet Count measurement | Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C1278039
signed informed consent.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients infected by the human immunodeficiency virus (hiv)
Beschreibung

HIV Infections

Datentyp

boolean

Alias
UMLS CUI [1]
C0019693
patients who do not fit inclusion criteria
Beschreibung

Inclusion criteria Mismatch

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1881865

Ähnliche Modelle

Eligibility Prostate Cancer NCT00126230

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients older than 18 years and less than 80 years
boolean
C0001779 (UMLS CUI [1])
Adenocarcinoma of prostate
Item
histologically-proven adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Secondary malignant neoplasm of bone Evidence | Progressive Disease Hormones refractory
Item
evidence of bone metastases and progressive, hormone-refractory, disease
boolean
C0153690 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C1335499 (UMLS CUI [2,1])
C0019932 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
Chemotherapy
Item
no previous chemotherapy
boolean
C0392920 (UMLS CUI [1])
Therapeutic radiology procedure | Radiotherapy to prostate | Therapeutic radiology procedure Bone lesion Single
Item
no previous radiotherapy, except radiotherapy directed to the prostate and/or to a single bony lesion
boolean
C1522449 (UMLS CUI [1])
C0948317 (UMLS CUI [2])
C1522449 (UMLS CUI [3,1])
C0238792 (UMLS CUI [3,2])
C0205171 (UMLS CUI [3,3])
Carcinoma | Basal cell carcinoma
Item
no previous carcinoma, except basal-cell carcinoma of the skin
boolean
C0007097 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
Renal function | Creatinine clearance measurement | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
adequate renal function: measured or calculated creatinine clearance > 60 ml/min
boolean
C0232804 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
Absolute neutrophil count | Platelet Count measurement | Serum total bilirubin measurement
Item
absolute granulocyte count ≥ 1,500/mm3, platelets ≥ 100,000 mm3, bilirubin ≤ 1.5 fold the upper normal value
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
Informed Consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
HIV Infections
Item
patients infected by the human immunodeficiency virus (hiv)
boolean
C0019693 (UMLS CUI [1])
Inclusion criteria Mismatch
Item
patients who do not fit inclusion criteria
boolean
C1512693 (UMLS CUI [1,1])
C1881865 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video